CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 807 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02324647
NCT02324647N/ACompleted

Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield

University Medical Center Groningen·observational·Posted Dec 24, 2014·Updated Jan 7, 2026

In Brief

An observational study for Adrenal Incidentaloma and Adrenocortical Carcinoma. Completed, enrolled 807 participants across 1 site.

Detailed Summary

Standard diagnostic work-up for adrenal incidentalomas (AI) consists of periodical biochemical analysis and CT-scanning in case the initial work-up does not demonstrate the presence of hormonal hypersecretion or adrenocortical carcinoma (ACC), respectively. The overall aim of this study is to improve the cost-effectiveness of the diagnostic strategy for AI. Cost-effectiveness of urine steroid profiling (USP) will be compared to the standard diagnostic strategy of repeated CT-imaging.

Study Details

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 24, 2014
Enrollment StartJan 1, 2015
Primary CompletionJun 1, 2023
TodayJul 2, 2026
Enrollment to primary: 8.4 yearsPosted 11.5 years ago